5.6.02: Canadian Biotechnology Issue
Two analysts and top management from sixteen sector firms examine the canadian biotechnology sector in this special 69-page Canadian Biotechnology issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    Healthcare Information Technology Issue & Pharmaceutical Industry Issue

  1. Canadian Biotechnology Stocks - In an in-depth (3,300 words) Analyst Interview, Claude Camiré, Analyst with Dundee Securities, examines the outlook for the sector and shares specific stock recommendations.
  2. Canadian Biotechnology Stocks - In an in-depth (4,100 words) Analyst Interview, Brian Bapty, Analyst part of the healthcare team at Raymond James Ltd. at Raymond James Ltd., examines the outlook for the sector and shares specific stock recommendations.
  3. CEO interviews (average 2,500 words). Top management of sixteen sector firms examine the outlook for their firm and the sector. Firms include:
    Aetna, Arius Research, Bioniche Life Sciences, Biophage Pharma, ConjuChem, Ecopia BioSciences, Generex Biotechnology, aemacure, IMI, International Wex Technologies, Neurochem, Oncolytics Biotech, SYN-X Pharma, Theratechnologies, Virtek Vision International, Warnex
    4. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE